Comment on: "Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society"
Minerva Urol Nephrol
.
2022 Dec;74(6):816-818.
doi: 10.23736/S2724-6051.22.05182-5.
Authors
Pawel Rajwa
1
2
,
Martina Maggi
3
,
Ignacio Puche-Sanz
4
,
Grzegorz Rempega
5
,
Shahrokh F Shariat
6
7
8
9
,
Fabio Zattoni
10
;
EAU-Young Academic Urologists (YAU) Prostate Cancer Working Party
Affiliations
1
Department of Urology, Medical University of Vienna, Vienna, Austria - pawelrajwa@gmail.com.
2
Department of Urology, Medical University of Silesia, Zabrze, Poland - pawelrajwa@gmail.com.
3
Department of Maternal-Infant and Urological Sciences, Sapienza University, Policlinico Umberto I Hospital, Rome, Italy.
4
Department of Urology, Instituto de Investigación Biosanitaria ibs.Granada, Hospital Universitario Virgen de las Nieves (HUVN), Granada, Spain.
5
Department of Urology, Medical University of Silesia, Zabrze, Poland.
6
Department of Urology, Medical University of Vienna, Vienna, Austria.
7
Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic.
8
Department of Urology, Weill Cornell Medical College, New York, NY, USA.
9
Department of Urology, University of Texas Southwestern, Dallas, TX, USA.
10
Unit of Urology, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
PMID:
36629815
DOI:
10.23736/S2724-6051.22.05182-5
No abstract available
Publication types
Comment
MeSH terms
Consensus
Delphi Technique
Humans
Male
Prostatic Neoplasms* / diagnosis
Prostatic Neoplasms* / therapy